Status:
RECRUITING
Novosyn® CHD vs Polyglactin 910 Suture to Close Wounds After Emergency or Elective Laparotomy or Laparoscopic Surgery
Lead Sponsor:
Aesculap AG
Collaborating Sponsors:
B.Braun Surgical SA
Conditions:
Surgical Site Infection
Eligibility:
All Genders
18+ years
Brief Summary
The aim of the study is to elucidate, if the colonization of bacteria is lower on the Novosyn® CHD suture compared to uncoated Polyglactin 910 suture, which will be assessed by the incidence of surgic...
Eligibility Criteria
Inclusion
- Patients undergoing an emergency or elective laparotomy or laparoscopic surgery.
- Written informed consent
- Age≥ 18 years
- Not incapacitated patient
Exclusion
- No exclusion criteria except patients with allergy or hypersensitivity to chlorhexidine
Key Trial Info
Start Date :
September 18 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
August 1 2028
Estimated Enrollment :
2998 Patients enrolled
Trial Details
Trial ID
NCT05966961
Start Date
September 18 2023
End Date
August 1 2028
Last Update
February 3 2025
Active Locations (4)
Enter a location and click search to find clinical trials sorted by distance.
1
Pineta Grande Hospital
Napoli, Italy
2
Hospital Clínico San Carlos
Madrid, Spain
3
Hospital Universitario de Canarias
Santa Cruz de Tenerife, Spain
4
Hospital Universitario Virgen del Rocío
Seville, Spain